Advanced search
Publication Cover
Renal Failure Volume 38, 2016 - Issue 9
Submit an article Journal homepage
663
Views
3
CrossRef citations to date
0
Altmetric
Clinical Study

Fasudil inhibits tissue factor and plasminogen activator Inhibitor-1 secretion by peripheral blood mononuclear cells in CAPD patients

Wenning LiDepartment of Nephrology, Hainan General Hospital, Haikou, Hainan, China;
,
Wen ChenDepartment of Nephrology, the Second Affiliated Hospital of Hainan Medical College, Haikou, Hainan, China;
,
Maowei XieDepartment of Nephrology, Hainan General Hospital, Haikou, Hainan, China;
,
Haiyang HuangCentral Laboratory, Hainan General Hospital, Haikou, Hainan, China
,
Huiluan SuDepartment of Nephrology, Hainan General Hospital, Haikou, Hainan, China;
,
Hui HanDepartment of Nephrology, Hainan General Hospital, Haikou, Hainan, China;
,
Daofa ZhangDepartment of Nephrology, Hainan General Hospital, Haikou, Hainan, China;
,
Ying ZhangDepartment of Nephrology, Hainan General Hospital, Haikou, Hainan, China;
,
Xiaohong YangDepartment of Nephrology, Hainan General Hospital, Haikou, Hainan, China;
,
Wentan XuDepartment of Nephrology, Hainan General Hospital, Haikou, Hainan, China;
,
Yan SuDepartment of Nephrology, Hainan General Hospital, Haikou, Hainan, China;
,
Wei WuDepartment of Nephrology, Hainan General Hospital, Haikou, Hainan, China;
,
Yun HuangDepartment of Nephrology, Hainan General Hospital, Haikou, Hainan, China;
,
Keying FuCentral Laboratory, Hainan General Hospital, Haikou, Hainan, China
&
Jiali WeiDepartment of Nephrology, Hainan General Hospital, Haikou, Hainan, China; Correspondence[email protected]
 show all
Pages 1359-1363 | Received 13 Dec 2015, Accepted 09 Jul 2016, Published online: 19 Oct 2016

References

  • Dubin R, Cushman M, Folsom AR, et al. Kidney function and multiple hemostatic markers: Cross sectional associations in the multi-ethnic study of atherosclerosis. BMC Nephrol. 2011;12:3.
  • Goluza E, Topalović MG, Hudolin T, Konosić S, Kocman IB, Perić M. Disorders of hemostasis in chronic renal failure and renal transplantation. Acta Med Croatica. 2011;65:337–347.
  • Poulikakos D, Banerjee D, Malik M. Risk of sudden cardiac death in chronic kidney disease. J Cardiovasc Electrophysiol. 2014;25:222–231.
  • Chitalia VC, Shivanna S, Martorell J, et al. Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor. Circulation. 2013;127:365–376.
  • Tanaka H, Sonoda M, Kashima K, et al. Impact of decreased renal function on coagulation and fibrinolysis in patients with non-valvular atrial fibrillation. Circ J. 2009;73:846–850.
  • Ansari I, Sheikh A, Ahmed SS, Jabbar Q, Ali S. Management of anemia and other hematologic derangements in patients with chronic kidney disease. Arab J Nephrol Transplant. 2014;7:13–19.
  • London GM, Druke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int. 1997;51:1678–1695.
  • Wand S, Schneider S, Meybohm P, Zacharowski K, Weber CF. Assessment of hemostatic changes after initiation of continuous venovenous hemodialysis. Clin Lab. 2015;61:379–387.
  • Preloznik Zupan I, Sabovic M, Salobir B, Buturovic Ponikvar J. Characterization of the pro-thrombotic state in CAPD patients. Ren Fail. 2008;30:597–602.
  • Bartens W, Nauck M, Schollmeyer P, Wanner C. EIevated lipoprotein (a) and fibrinogen serum levels increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1996;16:27–33.
  • Yamani MH, Starling RC, Young JB, et al. Acute vascular rejection is associated with up-regulation of vitronectin receptor (aVb3), increased expression of tissue factor, and activation of the extracellular matrix metalloproteinase induction system. J Heart Lung Transplant. 2002;21:983–989.
  • Stahl AL, Vaziri-Sani F, Heinen S, et al. Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation. Blood. 2008;111:5307–5315.
  • Broze GJ Jr. Tissue factor pathway inhibitor. Thromb Haemost. 1995;74:90–93.
  • Malyszko J, Malyszko JS, Mysliwiec M. Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis. Perit Dial Int. 2001;21:158–165.
  • Pawlak K, Mysliwiec M, Pawlak D. Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients. Thromb Haemost. 2009;102:49–55.
  • Karásek D, Vaverková H, Halenka M, Slavík L, Novotný D. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia. Thromb Res. 2009;123:466–475.
  • Ha BH, Morse EM, Turk BE, Boggon TJ. Signaling, regulation, and specificity of the type II p21-activated kinases. J Biol Chem. 2015;290:12975–12983.
  • Julian L, Olson MF. Rho-associated coiled-coil containing kinases (ROCK): Structure, regulation, and functions. Small GTPases. 2014;5:e29846.
  • Aikawa M, Voglic SJ, Sugiyama S, et al. Dietary lipid lowering reduces tissue factor expression in rabbit atheroma. Circulation. 1999;100:1215–1122.
  • Pretorius E, Lipinski B, Bester J, Vermeulen N, Soma P. Albumin stabilizes fibrin fiber ultrastructure in low serum albumin type 2 diabetes. Ultrastruct Pathol. 2013;37:254–257.
  • Koyama T, Nishida K, Ohdama S, et al. Determination of plasma tissue factor antigen and its clinical significance. Br J Hematol. 1994;84:343–347.
  • Kobayashi M, Yorioka N, Yamakido M. Hypercoagulability and secondary hyper-fibrinolysis may be related to abnormal lipid metabolism inpatients treated with continuous ambulatory peritoneal dialysis. Nephron. 1997;76:56–61.
  • Al-Wakeel J, Gader AM, Huraib S, et al. Coagulation inhibitors and fibrinolytic parameters in patients on peritoneal dialysis and haemodialysis. Int Urol Nephrol. 1996;28:255–261.
  • Goedde M, Siltter T, Schiffl H, Bechtel U, Schram W, Spangl M. Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patients. Perit Dial Int. 1997;17:162–170.
  • Zanin-Zhorov A, Waksal SD. ROCKing cytokine secretion balance in human T cells. Cytokine. 2015;72:224–225.
  • Slotta JE, Braun OO, Menger MD, Thorlacius H. Central role of rho kinase in lipopolysaccharide-induced platelet capture on venous endothelium. J Investig Med. 2008;56:720–725.
  • Jiang C, Huang H, Liu J, Wang Y, Lu Z, Xu Z. Fasudil, a rho-kinase inhibitor, attenuates bleomycin-induced pulmonary fibrosis in mice. Int J Mol Sci. 2012;13: 8293–8307.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.